Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series
Sign Up to like & getrecommendations! Published in 2024 at "Haemophilia"
DOI: 10.1111/hae.15094
Abstract: The management of bleeding events (BEs) in haemophilia A (HA) and B (HB) patients with inhibitors necessitates the use of bypassing agents. The recombinant factor VIIa bypassing agent eptacog beta has demonstrated efficacy at treating… read more here.
Keywords: real world; beta; effectiveness eptacog; eptacog beta ... See more keywords